Profile data is unavailable for this security.
About the company
Mochida Pharmaceutical Co Ltd is a Japan-based company principally engaged in the production and sale of drugs. The Pharmaceutical-related segment is engaged in the manufacture, purchase and sale of pharmaceutical products. The Company also conducts brokerage and management of real estate properties, the maintenance and management of buildings, the agency of personal affairs, accounting and purchasing businesses. The Healthcare segment is involved in the manufacture, purchase and sale of quasi drugs and cosmetic products.
- Revenue in JPY (TTM)105.16bn
- Net income in JPY5.69bn
- Incorporated1945
- Employees1.51k
- LocationMochida Pharmaceutical Co Ltd1-7, YotsuyaSHINJUKU-KU 160-8515JapanJPN
- Phone+81 333587211
- Fax+81 333587887
- Websitehttps://www.mochida.co.jp/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASKA Pharmaceutical Holdings Co Ltd | 64.14bn | 5.10bn | 67.79bn | 1.63k | 13.10 | 1.02 | 9.23 | 1.06 | 179.94 | 179.94 | 2,262.57 | 2,302.59 | 0.6706 | 1.40 | 4.18 | 39,300,860.00 | 5.33 | 5.50 | 7.26 | 7.07 | 48.86 | 47.56 | 7.95 | 7.98 | 1.39 | -- | 0.1361 | 16.60 | 2.06 | 4.07 | -32.39 | 51.04 | 9.49 | 31.48 |
| JCR Pharmaceuticals Co Ltd | 33.07bn | -4.76bn | 79.63bn | 987.00 | -- | 1.59 | -- | 2.41 | -38.86 | -38.86 | 267.09 | 386.12 | 0.3194 | 0.5309 | 2.43 | 33,507,600.00 | -4.54 | 5.86 | -7.10 | 9.33 | 65.73 | 73.83 | -14.20 | 13.60 | 0.666 | -26.06 | 0.4466 | 45.13 | -22.86 | 5.94 | -186.42 | -- | 15.37 | 20.11 |
| Nxera Pharma Co Ltd | 30.87bn | -2.32bn | 79.82bn | 374.00 | -- | 1.18 | 45.20 | 2.59 | -25.83 | -25.83 | 343.68 | 746.05 | 0.2072 | 1.48 | 6.96 | 82,534,760.00 | -1.56 | -1.71 | -1.72 | -1.85 | 73.95 | 84.07 | -7.51 | -10.93 | 3.11 | -- | 0.497 | -- | 125.87 | 24.28 | 32.74 | -- | 40.57 | -- |
| Katakura Industries Co Ltd | 40.12bn | 3.92bn | 87.19bn | 941.00 | 20.54 | 0.9384 | 12.53 | 2.17 | 120.54 | 120.54 | 1,233.12 | 2,638.59 | 0.2885 | 2.32 | 4.76 | 42,634,430.00 | 2.97 | 2.60 | 3.66 | 3.57 | 37.01 | 37.98 | 10.29 | 9.44 | 2.55 | -- | 0.0947 | 23.42 | -1.37 | -2.19 | 15.73 | 15.27 | -7.22 | 33.03 |
| Kyorin Pharmaceutical Co Ltd | 130.09bn | 9.09bn | 89.92bn | 2.00k | 9.48 | 0.6323 | 6.57 | 0.6912 | 158.16 | 158.16 | 2,264.40 | 2,372.28 | 0.7008 | 1.18 | 2.78 | 65,108,610.00 | 4.89 | 3.34 | 6.25 | 4.16 | 45.77 | 45.89 | 6.98 | 5.11 | 2.01 | -- | 0.1727 | 57.34 | 8.83 | 3.41 | 70.73 | 8.12 | 14.36 | -7.06 |
| Mochida Pharmaceutical Co Ltd | 105.16bn | 5.69bn | 105.82bn | 1.51k | 18.13 | 0.7888 | 12.27 | 1.01 | 160.36 | 160.36 | 2,966.32 | 3,686.67 | 0.6595 | 1.62 | 3.16 | 69,734,090.00 | 3.57 | 4.50 | 4.24 | 5.44 | 51.15 | 52.49 | 5.41 | 6.87 | 3.47 | 40.43 | 0.0026 | 43.01 | 2.21 | 0.6516 | 25.03 | 4.34 | 1.98 | 0.00 |
| Zeria Pharmaceutical Co Ltd | 87.31bn | 9.94bn | 108.95bn | 1.75k | 9.10 | 1.01 | 6.22 | 1.25 | 225.42 | 225.42 | 1,980.76 | 2,031.33 | 0.5638 | 1.51 | 3.70 | 50,006,380.00 | 6.44 | 4.67 | 9.95 | 7.47 | 73.25 | 72.17 | 11.42 | 9.02 | 0.9752 | -- | 0.3209 | 28.75 | 15.30 | 7.64 | 28.52 | 27.71 | 16.51 | 6.69 |
| Towa Pharmaceutical Co Ltd | 259.59bn | 18.99bn | 157.12bn | 4.79k | 7.91 | 0.8748 | 4.02 | 0.6053 | 385.70 | 385.70 | 5,273.63 | 3,486.39 | 0.5759 | 1.57 | 3.69 | 54,217,630.00 | 4.21 | 3.89 | 5.18 | 5.07 | 36.49 | 37.81 | 7.31 | 6.61 | 1.58 | -- | 0.5737 | 21.52 | 13.89 | 18.65 | 17.39 | 5.53 | 46.23 | 9.73 |
Data as of Jul 11 2025. Currency figures normalised to Mochida Pharmaceutical Co Ltd's reporting currency: Japanese Yen JPY
8.67%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 02 Jul 2025 | 795.42k | 2.12% |
| Nomura Asset Management Co., Ltd.as of 03 Jul 2025 | 759.40k | 2.03% |
| Nikko Asset Management Co., Ltd.as of 04 Jul 2025 | 354.90k | 0.95% |
| Daiwa Asset Management Co. Ltd.as of 30 May 2025 | 341.40k | 0.91% |
| BlackRock Fund Advisorsas of 03 Jul 2025 | 310.70k | 0.83% |
| Dimensional Fund Advisors LPas of 04 Jul 2025 | 206.69k | 0.55% |
| Norges Bank Investment Managementas of 31 Dec 2024 | 183.70k | 0.49% |
| Mitsubishi UFJ Asset Management Co., Ltd.as of 22 Jul 2024 | 139.20k | 0.37% |
| Charles Schwab Investment Management, Inc.as of 02 Jul 2025 | 85.42k | 0.23% |
| BlackRock Advisors (UK) Ltd.as of 02 Jul 2025 | 70.10k | 0.19% |
More ▼
Data from 31 Dec 2024 - 31 Mar 2025Source: FactSet Research Systems Inc.
